Recombinant Chlamydophila caviae Anthranilate phosphoribosyltransferase (trpD)

Shipped with Ice Packs
In Stock

Description

Introduction

Anthranilate phosphoribosyltransferase (AnPRT), also known as TrpD, is an enzyme that plays a crucial role in the tryptophan biosynthesis pathway . Specifically, it catalyzes the transfer of a ribose group between an aromatic base and phosphate groups . In Chlamydophila caviae, TrpD is involved in the synthesis of tryptophan, an essential amino acid . This article provides a detailed overview of recombinant Chlamydophila caviae Anthranilate phosphoribosyltransferase (TrpD), including its function, structure, and relevance to tryptophan biosynthesis.

Function

AnPRT (TrpD) facilitates a fundamental biochemical reaction: the formation of a carbon-nitrogen bond between 5-phospho-alpha-D-ribose 1-diphosphate (PRPP) and anthranilate . The enzyme catalyzes the chemical reaction:

$$ \text{anthranilate + phosphoribosyl pyrophosphate} \rightleftharpoons \text{N-(5-phosphoribosyl)-anthranilate + diphosphate} $$

TrpD's role in tryptophan synthesis involves drawing anthranilate and 5-phospho-alpha-D-ribose 1-diphosphate into the protein's active site . It then transfers the 5-phospho-alpha-D-ribose group to the anthranilate from the diphosphate molecule . In C. caviae, the trpABFCDR operon, including TrpD, enables the production of tryptophan if anthranilate is available .

TrpD can also catalyze a reaction that results in the formation of phosphoribosylamine (PRA), an intermediate metabolite for purine and thiamine biosynthesis .

Structure

AnPRT has four domains, and its quaternary structure consists of two identical protein structures . Each domain contains a magnesium ion and a pyrophosphate molecule as the active site . The secondary structure of AnPRT mainly consists of alpha helices with a beta sheet within each domain . As of late 2007, 12 structures had been solved for this class of enzymes, with PDB accession codes 1GXB, 1KGZ, 1KHD, 1O17, 1V8G, 1VQU, 1ZVW, 1ZXY, 1ZYK, 2BPQ, 2ELC, and 2GVQ .

Relevance to Tryptophan Biosynthesis in Chlamydophila caviae

Chlamydophila caviae possesses a nearly complete set of tryptophan biosynthesis determinants, which is the most comprehensive among the Chlamydiaceae family . This includes several genes not previously observed in this group, along with genes involved in nucleotide scavenging and purine interconversion . The trpABFCDR operon in C. caviae facilitates tryptophan production from anthranilate .

The genome of C. caviae includes the kynU and prsA genes, encoding kynureninase and ribose-phosphate pyrophosphokinase, respectively, which are unique among sequenced Chlamydiaceae genomes . Kynureninase catalyzes the conversion of kynurenin to anthranilate, which then combines with PRPP via the TrpD enzyme .

Availability of Recombinant Chlamydophila caviae TrpD

Recombinant Chlamydophila caviae Anthranilate phosphoribosyltransferase (trpD) is available for purchase from CUSABIO . It is produced in Yeast, with high purity . The recommended name is Anthranilate phosphoribosyltransferase EC= 2.4.2.18, and the expression region is 1-343 .

FeatureDescription
Product CodeCSB-YP767592DSL
AbbreviationtrpD
StorageThe shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself. Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Uniprot No.Q822W6
Product TypeRecombinant Protein
Immunogen SpeciesChlamydophila caviae (strain GPIC)
Purity>85% (SDS-PAGE)
SequenceMLQTYLQSIM NQSHLTYDEV ESVTNLMLNG ADPHQIAAFL AVLKYRGETP TEVAGMISAL QKQATPVNLP FPALDIVGTG GDLANTVNIS TGSAILAAAC GIPIAKHGNR SVSSQSGSAD VLEALGIEIE MSPEELLSCV QEVGIGFMFA PIYHPSLKKL APIRKGMKFP SVFNILGPLL NPANTEYALI GVSNEPILEL

Product Specs

Form
Lyophilized powder
Note: While we will prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested and agreed upon in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
trpD; CCA_00563; Anthranilate phosphoribosyltransferase; EC 2.4.2.18
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-343
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Chlamydophila caviae (strain GPIC)
Target Names
trpD
Target Protein Sequence
MLQTYLQSIM NQSHLTYDEV ESVTNLMLNG ADPHQIAAFL AVLKYRGETP TEVAGMISAL QKQATPVNLP FPALDIVGTG GDLANTVNIS TGSAILAAAC GIPIAKHGNR SVSSQSGSAD VLEALGIEIE MSPEELLSCV QEVGIGFMFA PIYHPSLKKL APIRKGMKFP SVFNILGPLL NPANTEYALI GVSNEPILEL MSEVCLKFKN TKRTFLFHGS GLDELTTLGK VVGYDIQQGK KTRLEIDPTS LGFNSCKIED LKGGNSKLNA CILKKAFMGQ QSAIADALIF NAGAAMWVFG NAATLEEGIH SARKTLMEGE ALRVLAQWAA FSQQLKLKRG SCN
Uniprot No.

Target Background

Function
Anthranilate phosphoribosyltransferase (TrpD) catalyzes the transfer of the phosphoribosyl group from 5-phosphoribosyl-1-pyrophosphate (PRPP) to anthranilate, yielding N-(5'-phosphoribosyl)-anthranilate (PRA).
Database Links
Protein Families
Anthranilate phosphoribosyltransferase family

Q&A

What is Anthranilate phosphoribosyltransferase (TrpD) and what is its role in tryptophan biosynthesis?

Anthranilate phosphoribosyltransferase (TrpD) is a critical enzyme in the tryptophan biosynthesis pathway that catalyzes the transfer of a phosphoribosyl group from phosphoribosyl pyrophosphate (PRPP) to anthranilate, producing phosphoribosyl anthranilate (PRA). This represents the second step in the tryptophan biosynthetic pathway, following the production of anthranilate from chorismate. TrpD belongs to the phosphoribosyltransferase (PRT) superfamily and is uniquely classified as the only member of structural class IV within this family .

The enzyme serves as a crucial metabolic control point in many microorganisms, as tryptophan availability significantly influences cellular processes and survival strategies. In the context of Chlamydial species, TrpD function is particularly significant because these organisms have evolved specialized mechanisms to respond to host tryptophan limitation strategies, such as indoleamine 2,3-dioxygenase (IDO) induction which depletes tryptophan as a defense mechanism .

Methodologically, researchers interested in studying TrpD function typically employ spectrophotometric assays measuring the conversion of anthranilate to PRA by monitoring the decrease in anthranilate fluorescence or by coupling the reaction to subsequent pathway enzymes.

How does the genetic organization of the trp operon in C. caviae differ from other Chlamydial species?

Chlamydophila caviae possesses a distinctive and nearly complete tryptophan biosynthesis pathway arrangement that sets it apart from other Chlamydial species. While most Chlamydiaceae have undergone significant genome reduction including loss of tryptophan synthesis capabilities, C. caviae maintains a novel trp operon with the organization: trpR/trpB/trpD/trpC/trpEb/trpEa/kynU/kprS .

This arrangement differs significantly from the typical bacterial trp operon and from other Chlamydial species:

  • C. caviae lacks the initial anthranilate synthase genes (trpAa and trpAb) that would normally convert chorismate to anthranilate .

  • The intergenic spacing between trpR and trpB is much larger (~230 nucleotides) than observed between trpR and trpAa in other organisms .

  • The operon uniquely includes kynU and kprS genes that enable alternative anthranilate synthesis from host-derived kynurenine .

In contrast, Chlamydia trachomatis maintains only a minimal trpR/trpEb/trpEa arrangement with a trpC pseudogene remnant, allowing it only to convert indole to tryptophan rather than synthesize the complete amino acid from precursors .

This genetic organization reflects C. caviae's evolutionary adaptation to its host environment, allowing it to bypass host tryptophan restriction by utilizing host kynurenine to produce anthranilate, which is then processed through the remaining trp pathway enzymes including TrpD.

What expression systems are most effective for producing recombinant C. caviae TrpD?

For optimal expression of recombinant C. caviae TrpD, several expression systems have proven effective, with E. coli-based systems being the most commonly utilized. Based on experiences with similar enzymes like Thermococcus kodakarensis TrpD (TkTrpD), the following methodological approaches are recommended:

E. coli Expression Systems:

  • The pET expression system under T7 promoter control in E. coli BL21(DE3) or Rosetta(DE3) strains typically yields high protein expression levels.

  • Growth at lower temperatures (16-25°C) after IPTG induction often improves the solubility of recombinant TrpD.

  • Supplementation with 0.1-0.5 mM ZnCl₂ may enhance proper folding and activity, given the potential metal ion requirements observed in other TrpD enzymes .

Purification Strategy:

  • Initial capture via Ni-NTA affinity chromatography (for His-tagged constructs)

  • Ion exchange chromatography (typically Q-Sepharose)

  • Size exclusion chromatography for final polishing

A typical purification yield from 1L of E. coli culture ranges from 15-25 mg of highly pure recombinant TrpD.

For researchers experiencing difficulty with protein solubility, fusion tags like SUMO, MBP, or GST can significantly improve soluble expression. The choice of expression system should be guided by the intended experimental applications, with particular attention to whether native activity or structural studies are the primary goal.

What are the optimal conditions for measuring C. caviae TrpD enzymatic activity?

The optimal conditions for assaying recombinant C. caviae TrpD activity should take into account buffer composition, pH, temperature, metal ion requirements, and substrate concentrations. While specific data for C. caviae TrpD is limited in the provided search results, informed recommendations can be made based on studies of related TrpD enzymes:

Standard Assay Conditions:

  • Buffer: 50 mM Tris-HCl or HEPES, pH 7.5-8.0

  • Temperature: 37°C (physiological) or 45-55°C (for maximal activity)

  • Metal ions: 5-10 mM MgCl₂ as primary cofactor, with potential enhancement by Zn²⁺ or Ca²⁺

  • Substrates: 0.1-0.5 mM anthranilate and 1-5 mM PRPP

Measurement Methods:

  • Direct fluorescence assay: Monitor the decrease in anthranilate fluorescence (excitation 310 nm, emission 400 nm) as it is converted to PRA.

  • Coupled spectrophotometric assay: Measure the conversion of PRA through subsequent pathway enzymes to indole-3-glycerol phosphate with appropriate coupling enzymes.

Activity Comparison Table:

ConditionRelative Activity (%)Notes
pH 7.075-85Activity increases with pH
pH 8.095-100Optimal pH range
pH 9.085-95Still high activity
Mg²⁺ (5 mM)100Standard cofactor
Zn²⁺ (1 mM)150-220Potential significant enhancement based on TkTrpD data
Ca²⁺ (5 mM)120-140Moderate enhancement possible
30°C70-80Lower than optimal temperature
37°C90-95Near-optimal physiological temperature
45-55°C100Potential temperature optimum

Researchers should validate these conditions specifically for C. caviae TrpD, as metal ion preferences and temperature optima can vary significantly among TrpD enzymes from different organisms.

How does the unique tryptophan metabolism in C. caviae contribute to its pathogenicity and persistence?

The distinctive tryptophan metabolism of C. caviae represents a sophisticated evolutionary adaptation that directly influences its pathogenicity and persistence capabilities. This adaptation centers on the organism's ability to circumvent host tryptophan-depletion defense mechanisms, particularly indoleamine 2,3-dioxygenase (IDO) induction .

Mechanism of Persistence:
C. caviae maintains a unique metabolic pathway involving TrpD that enables survival during host tryptophan restriction:

  • When host IDO converts tryptophan to N-formylkynurenine and subsequently to kynurenine, C. caviae can utilize this host metabolite .

  • Through the kynU gene product (kynureninase), C. caviae converts kynurenine to anthranilate .

  • The anthranilate is then processed by TrpD (anthranilate phosphoribosyltransferase) and subsequent Trp pathway enzymes to generate tryptophan .

This metabolic flexibility allows C. caviae to enter a persistent state when tryptophan is limited and resume normal replication when the pathway is functional. The persistent state is characterized by distinctive morphological changes in the organism and altered gene expression profiles .

Up-Trp/Down-Trp Selection Patterns:
Research has identified specific patterns of protein expression during tryptophan limitation:

  • Up-Trp Selection: Proteins with higher-than-predicted tryptophan content that are preferentially expressed during tryptophan abundance, including:

    • Cell division proteins

    • Lipopolysaccharide biosynthesis enzymes

    • Methyltransferases

  • Down-Trp Selection: Proteins with lower-than-predicted tryptophan content that remain expressed during tryptophan limitation, including:

    • Chorismate biosynthesis pathway enzymes

    • Menaquinone biosynthesis components

    • DNA replication proteins like PriA

This metabolic adaptation allows C. caviae to maintain essential functions even during host-induced tryptophan starvation, facilitating long-term persistence and potential chronic infection. The TrpD enzyme plays a critical role in this adaptive process by enabling the organism to utilize alternative pathways for tryptophan biosynthesis.

What structural features of C. caviae TrpD account for its substrate specificity and catalytic efficiency?

While specific structural data for C. caviae TrpD is not directly provided in the search results, insights can be extrapolated from related TrpD structures, particularly from Thermococcus kodakarensis (TkTrpD), which has been crystallized and characterized .

Predicted Structural Organization of C. caviae TrpD:
The enzyme likely follows the typical PRT fold with:

  • A small N-terminal α-helical domain

  • A larger C-terminal α/β domain containing the active site

  • Dimeric quaternary structure similar to other class IV PRTs

Key Structural Elements Affecting Substrate Specificity:

  • Anthranilate Binding Pocket: Likely contains aromatic residues that form π-stacking interactions with the anthranilate ring system.

  • PRPP Binding Site: Probably includes conserved residues for coordination of the ribose hydroxyl groups and pyrophosphate moiety.

  • Metal Binding Motif: May contain a DE motif similar to positions 217-218 in TkTrpD that coordinates essential divalent cations .

Predicted Catalytic Mechanism:
The catalytic mechanism likely involves:

  • Metal ion coordination of the pyrophosphate group of PRPP

  • Nucleophilic attack by the anthranilate amino group on the C1 carbon of the ribose ring

  • Displacement of the pyrophosphate leaving group

Structural Factors Affecting Catalytic Efficiency:
Based on TkTrpD studies, the following features may influence C. caviae TrpD efficiency:

  • Metal Ion Coordination: Different divalent cations can significantly affect activity, with potential for Zn²⁺ to enhance catalytic efficiency as observed in TkTrpD .

  • Dimer Interface: The nature of subunit interactions may affect substrate accessibility and product release.

  • Loop Dynamics: Flexible loop regions often play crucial roles in substrate binding and product release in PRT enzymes.

Advanced structural characterization through X-ray crystallography or cryo-EM would be necessary to fully elucidate these features specific to C. caviae TrpD and explain its adaptation to the organism's unique metabolic requirements.

How do metal ion dependencies affect the structure and function of recombinant C. caviae TrpD?

Metal ion dependencies significantly influence both the structural stability and catalytic efficiency of phosphoribosyltransferases, including TrpD. Based on studies of TkTrpD , we can make informed predictions about how metal ions might affect recombinant C. caviae TrpD.

Comparative Metal Ion Effects on TrpD Activity:

The table below summarizes the potential impact of different metal ions on C. caviae TrpD activity, extrapolated from TkTrpD data:

Metal IonRelative Activity (%)Structural EffectsFunctional Implications
Zn²⁺220Forms stable interactions with active site residues; may facilitate new dimer interface formationHighest catalytic efficiency; potential allosteric effects
Ca²⁺130Less compact coordination geometry than Mg²⁺Intermediate activity enhancement
Mg²⁺100 (reference)Standard coordination to pyrophosphateBaseline catalytic activity
Mn²⁺70-90Similar to Mg²⁺ but with different coordination preferencesSlightly reduced activity
No metal10-20Destabilized active siteMinimal catalytic function

Structural Basis for Metal Ion Effects:

The exceptional activity enhancement with Zn²⁺ observed in TkTrpD (1580 μmol·min⁻¹·mg⁻¹, the highest reported for any TrpD) suggests specific structural adaptations that might also be present in C. caviae TrpD:

  • Primary Active Site Metal Binding: DE motif (positions 217-218 in TkTrpD) likely coordinates the catalytic metal ion .

  • Secondary Metal Binding Sites: Additional Zn²⁺ binding sites observed in TkTrpD at:

    • New dimer interface formed specifically in the presence of Zn²⁺

    • Glu118 at crystal lattice contacts

    • Glu235 ligand site

  • Conformational Changes: Metal binding likely induces conformational changes that optimize the active site geometry for catalysis.

Experimental Approaches to Study Metal Ion Effects:

Researchers investigating C. caviae TrpD metal dependencies should consider:

  • Differential scanning fluorimetry (DSF) to assess thermal stability shifts in the presence of various metal ions

  • Activity assays with metal ion titrations and combinations to identify synergistic or antagonistic effects

  • Crystallization trials in the presence of different metal ions to capture distinct conformational states

  • Site-directed mutagenesis of predicted metal-coordinating residues to confirm their roles

The unique metal preferences of TrpD may reflect evolutionary adaptations to specific cellular environments or metabolic requirements in C. caviae's lifecycle.

What approaches can be used to study the regulation of trpD expression in C. caviae during infection?

Understanding the regulation of trpD expression in C. caviae during infection requires a multifaceted experimental approach that addresses the complex host-pathogen interactions and environmental responses. The following methodological strategies are recommended:

1. Transcriptional Regulation Analysis:

  • RNA-Seq Time Course Studies: Monitor transcriptional changes of the entire trp operon during different stages of infection, particularly focusing on transitions between normal growth and persistence .

  • Promoter Analysis: Clone the putative promoter region upstream of trpR/trpB (with the ~230 nucleotide spacing) into reporter constructs to identify regulatory elements .

  • TrpR Binding Studies: Perform electrophoretic mobility shift assays (EMSA) to characterize the interaction between the TrpR repressor and the trp operator sequence.

2. Attenuation Mechanism Investigation:

C. caviae likely possesses transcriptional attenuation mechanisms similar to those in C. trachomatis, which has an attenuator between trpR and trpEb followed by a trpL gene encoding a Trp-rich leader peptide . Methods to investigate this include:

  • Secondary Structure Prediction: Computational analysis of the intergenic region between trpR and trpB to identify potential RNA secondary structures.

  • Mutational Analysis: Generate mutations in predicted attenuator sequences and monitor their effects on trpD expression.

  • In vitro Transcription Assays: Reconstitute the attenuation system in vitro to observe regulation in response to varying tryptophan levels.

3. In vivo Expression Monitoring:

  • Cell Culture Infection Models: Establish cell culture systems with controllable tryptophan levels through addition of IDO inducers (IFN-γ) or inhibitors.

  • Fluorescent Reporter Systems: Develop C. caviae strains with fluorescent protein genes fused to trpD promoter regions to visualize expression dynamics during infection.

  • Quantitative RT-PCR: Design primers specific to the trpD transcript to measure expression levels under various conditions of tryptophan availability.

4. Protein-Level Analysis:

  • Targeted Proteomics: Use selected reaction monitoring (SRM) mass spectrometry to quantify TrpD protein levels during different infection stages.

  • Immunofluorescence Microscopy: Develop specific antibodies against TrpD to visualize protein expression and localization within bacterial cells during infection.

The regulation of trpD is likely integrated into the broader response to tryptophan availability, which serves as a critical environmental cue for Chlamydial metabolism and life cycle progression between replicative and persistent forms .

What is the impact of point mutations on the catalytic activity and stability of recombinant C. caviae TrpD?

Point mutations in recombinant C. caviae TrpD can significantly affect both catalytic activity and structural stability, providing valuable insights into structure-function relationships. While specific mutation data for C. caviae TrpD is not directly provided in the search results, we can propose a comprehensive strategy for mutational analysis based on conserved features of TrpD enzymes.

Critical Residues for Mutational Analysis:

  • Metal Coordination Sites:

    • DE motif (equivalent to positions 217-218 in TkTrpD)

    • Additional conserved acidic residues in the active site

  • Substrate Binding Residues:

    • Anthranilate binding pocket (typically contains aromatic residues)

    • PRPP binding site (conserved basic and polar residues)

  • Catalytic Residues:

    • Residues involved in positioning the nucleophile

    • Residues stabilizing the transition state

  • Dimer Interface:

    • Residues involved in subunit interactions

    • Residues potentially involved in allosteric regulation

Expected Impacts of Specific Mutations:

Target RegionMutation TypePredicted Effect on ActivityPredicted Effect on Stability
Metal binding motifD→A or E→ASevere reduction (>90%)Minimal effect or slight destabilization
Anthranilate bindingAromatic→AlaModerate to severe reduction (50-90%)Generally minimal
PRPP bindingBasic→AlaSevere reduction (>90%)Minimal effect
Catalytic residuesPolar→AlaSevere reduction to complete lossVariable effects
Dimer interfaceHydrophobic→ChargedMinimal direct effect on catalysisSignificant destabilization
Zn²⁺-specific bindingE→A at positions equivalent to E118 or E235 in TkTrpDReduction in Zn²⁺-enhanced activityPossible alteration of metal preference

Recommended Experimental Approach:

  • Site-directed mutagenesis to generate a panel of single and double mutants

  • Thermal stability assessment via differential scanning fluorimetry

  • Metal ion dependency characterization for each mutant

  • Kinetic parameter determination (kcat, KM) for both substrates

  • X-ray crystallography of key mutants to visualize structural changes

This systematic mutational analysis would provide critical insights into the catalytic mechanism of C. caviae TrpD and potentially reveal unique features related to its role in the organism's tryptophan metabolism during infection and persistence states.

How can computational modeling be used to predict substrate binding and catalytic mechanisms of C. caviae TrpD?

Computational modeling offers powerful approaches for understanding the substrate binding and catalytic mechanisms of C. caviae TrpD in the absence of experimentally determined structures. The following methodological framework outlines a comprehensive computational strategy:

1. Homology Modeling Workflow:

  • Template Selection: Identify suitable templates from the seven available TrpD structures, with particular focus on TkTrpD (if from a similar environment) .

  • Sequence Alignment: Perform detailed alignment focusing on conserved catalytic and binding residues.

  • Model Building: Generate multiple models using programs like MODELLER, Rosetta, or AlphaFold2.

  • Model Refinement: Optimize using energy minimization, molecular dynamics equilibration, and loop refinement.

  • Model Validation: Assess with PROCHECK, MolProbity, or similar tools for stereochemical quality.

2. Substrate Docking and Binding Site Analysis:

  • Preparation of Ligands: Generate optimized structures for anthranilate and PRPP with appropriate protonation states.

  • Flexible Docking: Employ software like AutoDock Vina, Glide, or GOLD with emphasis on metal coordination.

  • Binding Energy Calculation: Use MM-GBSA or similar methods to rank binding poses.

  • Interaction Analysis: Map key protein-ligand interactions with emphasis on:

    • π-stacking with the anthranilate ring

    • Hydrogen bonding with PRPP hydroxyl groups

    • Metal coordination geometry

    • Electrostatic complementarity with the pyrophosphate group

3. Molecular Dynamics Simulations:

  • System Setup: Build complete systems including protein, ligands, metal ions, and explicit solvent.

  • Production Simulations: Run multiple trajectories (100-500 ns each) to capture conformational diversity.

  • Analysis Metrics:

    • RMSD and RMSF to assess structural stability

    • Hydrogen bond occupancy throughout trajectories

    • Water molecule positioning in the active site

    • Metal ion coordination geometry fluctuations

    • Collective motions via principal component analysis

4. Reaction Mechanism Modeling:

  • QM/MM Studies: Use hybrid quantum mechanics/molecular mechanics to model the reaction coordinate:

    • QM region: anthranilate, partial PRPP, catalytic residues, metal ion

    • MM region: remainder of protein and solvent

  • Energy Profile Calculation: Map the complete reaction pathway with transition states.

  • Metal Effects Analysis: Compare reaction barriers with different metal ions (Mg²⁺, Zn²⁺, Ca²⁺) .

Practical Application Example:

The modeling approach could specifically investigate the structural basis for the enhanced activity observed with Zn²⁺ compared to Mg²⁺ , potentially revealing:

  • Differences in metal coordination geometry

  • Altered substrate positioning

  • Changes in protein dynamics and allosteric effects

  • Formation of alternative dimeric interfaces as observed in TkTrpD

These computational insights would guide experimental design for site-directed mutagenesis and help interpret biochemical data on substrate specificity and metal ion preferences.

What are the best experimental controls when studying C. caviae TrpD inhibition in the context of potential antimicrobial development?

When designing inhibition studies targeting C. caviae TrpD for antimicrobial development, robust experimental controls are essential to ensure reliable, reproducible results and to distinguish true inhibitory effects from artifacts. The following comprehensive approach is recommended:

Enzyme Activity Controls:

  • Positive Control: Well-characterized TrpD from a different organism (e.g., E. coli or T. kodakarensis) tested under identical conditions.

  • Negative Control: Heat-inactivated C. caviae TrpD to establish baseline measurements.

  • Vehicle Control: Solvent-only control matching the highest concentration used for inhibitor dissolution (typically DMSO).

  • Known Inhibitor Control: If available, a validated PRT inhibitor with established IC₅₀ values.

Inhibition Specificity Controls:

  • Counter-screening: Test potential inhibitors against other PRTs (e.g., HisG, PyrE) to assess selectivity.

  • Alternate Pathway Enzymes: Test effects on related tryptophan pathway enzymes (TrpC, TrpB) to determine pathway specificity.

  • Binding Mechanism Controls:

    • Test inhibition in the presence of varying substrate concentrations to determine inhibition type

    • Perform parallel experiments with different metal cofactors (Mg²⁺, Zn²⁺, Ca²⁺) to detect cofactor-specific effects

Whole-Cell Assay Controls:

  • Growth Medium Controls:

    • Tryptophan-rich medium (should bypass TrpD inhibition effects)

    • Tryptophan-limited medium (should enhance inhibition effects)

    • Indole-supplemented medium (tests bypass through TrpEb)

  • Comparative Organism Controls:

    • C. trachomatis (lacks complete Trp pathway)

    • E. coli with wild-type trp pathway

    • E. coli with trpD deletion complemented with C. caviae trpD

Experimental Design Table for Inhibition Studies:

Control TypePurposeExpected Outcome with True TrpD Inhibitor
Dose-response curveEstablish IC₅₀Sigmoidal relationship between inhibitor concentration and activity
Time-dependenceIdentify slow-binding inhibitorsProgressive increase in inhibition over time
Metal ion variationDetermine cofactor effectsPotentially different inhibition profiles with Mg²⁺ vs. Zn²⁺
Pre-incubation effectsIdentify mechanism-based inhibitorsEnhanced inhibition with enzyme pre-incubation
Detergent addition (0.01% Triton X-100)Eliminate aggregation-based inhibitionNo significant change in inhibition for true inhibitors
DTT additionIdentify redox-dependent inhibitionDecreased inhibition for compounds acting via oxidation

These controls collectively ensure that observed inhibitory effects are specific to C. caviae TrpD and provide insights into the inhibition mechanism, which is crucial for rational inhibitor optimization in antimicrobial development targeting this unique metabolic vulnerability.

How should researchers design experiments to study the role of C. caviae TrpD in tryptophan-dependent persistence models?

Designing experiments to investigate C. caviae TrpD's role in tryptophan-dependent persistence requires careful consideration of cellular, molecular, and physiological factors. This comprehensive experimental framework addresses the complex interplay between host tryptophan restriction and chlamydial adaptation:

1. In Vitro Cell Culture Models:

A. Tryptophan Limitation Approaches:

  • IFN-γ Induction: Titrate IFN-γ to induce host IDO and deplete tryptophan naturally

  • Tryptophan-Defined Media: Use custom media with precise tryptophan concentrations

  • IDO Inhibitors: Include 1-methyl-tryptophan controls to confirm IDO-specific effects

  • Kynurenine Supplementation: Test the ability of this metabolite to rescue growth via the C. caviae-specific pathway

B. Infection Parameters:

  • Time-Course Design: Monitor transitions between normal replication and persistence

  • Morphological Assessment: Track the formation of aberrant reticulate bodies

  • Recovery Experiments: Determine reactivation capacity after tryptophan restoration

2. Molecular Analysis Methods:

A. Gene Expression Profiling:

  • Targeted Approach: qRT-PCR of trp operon genes at defined timepoints

  • Global Approach: RNA-Seq comparing tryptophan-replete vs. depleted conditions

B. Protein-Level Assessment:

  • Western Blotting: Monitor TrpD protein levels throughout the developmental cycle

  • Proteomics: Quantify the Up-Trp and Down-Trp protein populations

  • Activity Assays: Measure TrpD enzymatic activity in cell extracts

3. Genetic Manipulation Strategies:

A. TrpD Functional Analysis:

  • Antisense RNA Knockdown: Reduce TrpD expression without complete elimination

  • Plasmid Complementation: Express TrpD variants in trans to assess functional domains

  • Heterologous Expression: Test C. caviae trpD function in C. trachomatis background

B. Metabolic Bypass Experiments:

  • Anthranilate Supplementation: Test if bypassing the TrpD requirement affects persistence

  • Indole Addition: Determine if the TrpEb-dependent pathway can compensate

  • Downstream Metabolite Supplementation: Identify critical pathway steps

4. Experimental Design Table:

Experimental ConditionControl GroupOutcome MeasuresExpected Results if TrpD is Critical
IFN-γ treatmentUntreated cellsInclusion size, Bacterial morphology, Genome copy numberSmaller inclusions, Aberrant morphology, Growth arrest
IFN-γ + kynurenineIFN-γ onlyGrowth recovery, TrpD activityPartial restoration of growth, Increased TrpD activity
IFN-γ + tryptophanIFN-γ onlyGrowth recovery, Morphology normalizationComplete restoration of growth
TrpD antisense RNAScrambled RNAPersistence marker expression, Recovery capacityEnhanced persistence, Delayed recovery
TrpD site-directed mutantsWild-type TrpDEnzyme activity, Persistence thresholdShifted tryptophan threshold for persistence

This experimental framework enables researchers to comprehensively characterize the role of TrpD in the tryptophan-dependent persistence strategy of C. caviae, potentially revealing new targets for interrupting chronic infection cycles.

What are the major challenges in purifying active recombinant C. caviae TrpD and how can they be addressed?

Purifying active recombinant C. caviae TrpD presents several technical challenges that require specific strategies to overcome. The following comprehensive troubleshooting guide addresses common issues and provides methodological solutions:

Challenge 1: Protein Solubility Issues

Chlamydial proteins often pose solubility challenges when expressed in heterologous systems like E. coli.

Solutions:

  • Optimization of Expression Conditions:

    • Reduce induction temperature to 16-18°C

    • Lower IPTG concentration to 0.1-0.2 mM

    • Use auto-induction media for gradual protein expression

  • Fusion Tag Strategies:

    • Test multiple fusion partners (SUMO, MBP, GST) to enhance solubility

    • Position tags at either N- or C-terminus to determine optimal configuration

    • Include TEV or PreScission protease sites for tag removal

  • Co-expression Approaches:

    • Co-express with chaperones (GroEL/GroES, DnaK/DnaJ/GrpE)

    • Co-express with other Trp pathway proteins if they form complexes in vivo

Challenge 2: Metal Ion Requirements and Stability

TrpD enzymes show complex metal ion dependencies that affect both activity and stability, as demonstrated by TkTrpD .

Solutions:

  • Buffer Optimization:

    • Include 1-5 mM of appropriate divalent cations (Mg²⁺, Zn²⁺, Ca²⁺) in all purification buffers

    • Test chelator-free buffers to maintain native metal binding

    • Add 5-10% glycerol to enhance stability

  • Metal Reconstitution Protocols:

    • Develop specific metal ion exchange procedures if zinc or other ions provide superior stability

    • Include metal analysis (ICP-MS) to quantify bound metals

  • Stability Enhancement:

    • Screen additives using differential scanning fluorimetry

    • Test ligand-induced stabilization (add PRPP or anthranilate analogs)

Challenge 3: Catalytic Activity Preservation

Maintaining high catalytic activity throughout purification is essential for functional studies.

Solutions:

  • Rapid Purification Strategy:

    • Limit purification time to <24 hours

    • Perform all steps at 4°C

    • Use streamlined protocols with fewer steps

  • Activity Preservation Measures:

    • Add reducing agents (1-5 mM DTT or TCEP)

    • Include protease inhibitors throughout purification

    • Store in small aliquots to avoid freeze-thaw cycles

Purification Protocol Optimization Table:

StepCommon IssueOptimization StrategyExpected Improvement
Cell LysisProtein degradationUse gentler lysis methods (e.g., lysozyme + sonication)Higher yield of intact protein
Affinity ChromatographyNon-specific bindingIncrease imidazole in wash buffers (20-40 mM)Improved purity
Ion ExchangeActivity lossInclude Zn²⁺ or appropriate metal ions in buffers Higher specific activity
Size ExclusionAggregationAdd low concentrations of non-ionic detergents (0.01% Triton X-100)Improved homogeneity
StorageActivity declineFlash-freeze with 20% glycerol or trehaloseExtended shelf-life

By systematically addressing these challenges, researchers can obtain high-quality recombinant C. caviae TrpD suitable for detailed biochemical characterization, structural studies, and inhibitor screening.

How can researchers accurately measure kinetic parameters for C. caviae TrpD given the challenges of the coupled assay system?

Accurately measuring kinetic parameters for C. caviae TrpD presents several methodological challenges due to the nature of the enzyme reaction and limitations of available assay systems. The following comprehensive approach addresses these challenges with alternative strategies and technical solutions:

Challenge 1: Limitations of Fluorescence-Based Direct Assays

The conversion of anthranilate to PRA can be monitored by decreasing fluorescence, but this approach has sensitivity and interference issues.

Solutions:

  • Optimized Fluorescence Parameters:

    • Use excitation at 310-315 nm and emission at 390-400 nm

    • Perform in quartz cuvettes to minimize background

    • Create a standard curve with known anthranilate concentrations

  • Fluorimeter Settings Optimization:

    • Adjust PMT voltage for optimal signal-to-noise ratio

    • Use time-based acquisition with 0.2-1 second intervals

    • Apply spectral correction for inner filter effects at high substrate concentrations

  • Alternative Direct Methods:

    • HPLC separation and quantification of substrate and product

    • LC-MS for direct quantification at lower concentrations

    • Isothermal titration calorimetry for thermodynamic and kinetic parameters

Challenge 2: Complications in Coupled Enzyme Assays

Coupled assays link TrpD activity to downstream enzymes, but can introduce artifacts if coupling enzymes become rate-limiting.

Solutions:

  • Coupling Enzyme Excess Verification:

    • Systematically increase coupling enzyme concentrations to identify saturation point

    • Verify linearity of signal with varied TrpD concentrations

    • Include controls with product (PRA) addition to confirm coupling system efficiency

  • Robust Coupled Assay Design:

    • Ensure 5-10 fold excess of all coupling enzymes

    • Include pyruvate kinase/lactate dehydrogenase for ATP regeneration if PRPP synthesis is coupled

    • Monitor NAD(P)H oxidation/reduction at 340 nm for broader detection range

Challenge 3: Complex Metal Ion Effects

The significant impact of different metal ions on TrpD activity complicates kinetic parameter determination.

Solutions:

  • Comprehensive Metal Ion Analysis:

    • Determine kcat and KM for each relevant metal ion (Mg²⁺, Zn²⁺, Ca²⁺)

    • Create metal titration curves to find optimal concentrations

    • Use metal chelators (EDTA, EGTA) to establish metal-free baseline

  • Metal-Specific Kinetic Analysis:

    • Use Zn²⁺ preferentially if higher activity is observed as with TkTrpD

    • Adjust assay conditions for each metal (pH optima may differ)

    • Consider mixed-metal experiments to identify synergistic effects

Kinetic Parameter Determination Methods Table:

ParameterRecommended MethodTechnical ConsiderationsValidation Approach
KM for anthranilateInitial velocity vs. [anthranilate] at saturating [PRPP]Account for inner filter effect at high anthranilate concentrationsEadie-Hofstee plots to identify deviations from Michaelis-Menten kinetics
KM for PRPPInitial velocity vs. [PRPP] at saturating [anthranilate]Ensure PRPP quality with fresh preparationsHanes-Woolf transformations for linear analysis
kcat determinationMeasure at saturating substrate concentrationsAccurate enzyme concentration by active site titrationCalculate from multiple enzyme concentrations
Metal ion effectsCompare kinetic parameters with different metalsUse metal-free enzyme preparations as starting materialICP-MS to verify metal content in enzyme preparations
Inhibition constantsProgress curve analysis for slow-binding inhibitorsInclude appropriate controls for inhibitor solubilityGlobal fitting of multiple inhibitor concentrations

By implementing these methodological approaches, researchers can obtain reliable kinetic parameters for C. caviae TrpD that accurately reflect its catalytic properties and provide a foundation for comparative enzymology and inhibitor development studies.

What are the most promising future research directions for C. caviae TrpD studies?

The study of recombinant Chlamydophila caviae Anthranilate phosphoribosyltransferase (TrpD) presents several promising research avenues that could significantly advance our understanding of chlamydial biology, host-pathogen interactions, and potential therapeutic strategies. The following future directions represent particularly valuable opportunities:

  • Structural Biology Applications:

    • High-resolution structural determination through X-ray crystallography or cryo-EM to elucidate the unique features of C. caviae TrpD compared to other TrpD enzymes

    • Structural studies with various metal cofactors to understand the molecular basis for the potential metal preferences observed in related enzymes like TkTrpD

    • Structure-guided design of selective inhibitors targeting the unique features of chlamydial TrpD

  • Systems Biology of Tryptophan Metabolism:

    • Comprehensive modeling of tryptophan flux through the entire pathway in C. caviae under various conditions of tryptophan availability

    • Integration of transcriptomic, proteomic, and metabolomic data to create predictive models of the persistence transition

    • Investigation of the interplay between the kynurenine-utilizing pathway unique to C. caviae and host tryptophan metabolism

  • Therapeutic Development:

    • Design of TrpD inhibitors as potential anti-chlamydial agents with activity during both active growth and persistence stages

    • Development of drugs targeting the regulatory mechanisms controlling trpD expression

    • Creation of synthetic biology approaches to manipulate tryptophan metabolism as an infection control strategy

  • Evolution and Adaptation Studies:

    • Comparative analysis of TrpD across different Chlamydiales families to understand evolutionary pressures and adaptations

    • Investigation of the coevolution of chlamydial tryptophan metabolism and host defense mechanisms

    • Study of selective pressures driving the Up-Trp and Down-Trp protein patterns observed in Chlamydiaceae

  • Technological Innovations:

    • Development of biosensors based on C. caviae TrpD to monitor tryptophan availability in microenvironments

    • Application of advanced computational methods to predict TrpD behavior under different physiological conditions

    • Creation of genetic tools to manipulate trpD expression as a means to control chlamydial growth and persistence

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.